Lucid Lane — a virtual provider of opioid prescription management and SUD treatment services — has landed $16 million in Series A funding, Behavioral Health Business reports.
The round was led by Accel, with participation from Battery Ventures, AME Cloud Ventures, Morado Ventures and strategic angel investors. Battery Ventures also provided seed funding to Lucid Lane in May 2020, according to fundraising tracking site Crunchbase.
Lucid Lane was founded in 2017 and is based in Los Altos, California. The company focuses on helping those who have developed medication addictions following major medical procedures or who need help tapering their medication use during their recovery. Read more.
